← Back to stories

India's COVID-19 Crisis and Government Response

healthpoliticsSignificance: 8/10

The Facts

India recorded 330,000 new COVID-19 cases and 2,263 deaths in a single day, with active cases exceeding 2.4 million. The Indian drug regulator granted restricted emergency use approval to Zydus Cadila's Pegylated Interferon drug (Virafin) for COVID-19 treatment. The Indian government announced it will provide 5 kg of free food grains to approximately 800 million poor beneficiaries for May and June 2021.

How different outlets are framing this

The Times of India's coverage emphasizes both the severity of India's COVID-19 crisis and the government's response measures. The outlet highlights concerns about potential undercounting of deaths, with reports of bodies piling up at crematoriums suggesting the official death toll may not reflect the true extent of the crisis. Simultaneously, the Times of India gives prominent coverage to positive developments, including the approval of a new treatment drug and the government's food grain distribution program for the poor.

The Hindu's brief coverage focuses primarily on administrative decisions, mentioning school reopenings in Rajasthan while contextualizing India's situation within broader global concerns about the Delta variant affecting Europe and Asia. This framing presents India's crisis as part of a wider international challenge rather than emphasizing the country's specific struggles. The outlet's coverage appears more restrained in highlighting the dramatic scale of India's current wave compared to the Times of India's more detailed reporting on the crisis indicators.

Source Articles